DMC Glb Stock (NASDAQ:BOOM), Trade Ideas

DMC Glb

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Long Ideas

News

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

BOOM

BUSE

MTDR

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Insiders Buying Bristol-Myers Squibb And 3 Other Stocks

Penny Stocks

RNGR

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.

Top 5 Energy Stocks That Could Blast Off This Quarter

MIND

NINE

Top 4 Energy Stocks That Are Preparing To Pump This Month

DMC Global Inc

BOOM LOGISTICS LTD ORD by Boom Logistics Ltd.

Boom Logistics Ltd

Boomer Holdings Inc

Stifel analyst Stephen Gengaro maintains DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) with a Buy and lowers the price target from $28 to $27.

Price Target

Analyst Ratings

Stifel Maintains Buy on DMC Glb, Lowers Price Target to $27

Guidance

DMC Global Sees Q1 2024 Revenue $168M-$178M Vs $170.567M Est.

DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
DMC Glb missed estimated earnings by 23.53%, reporting an EPS of $0.26 versus an estimate of $0.34.
Revenue was down $1.04 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.04 which was followed by a 9.95% drop in the share price the next day.
Here's a look at DMC Glb's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.54</td>
<td>0.41</td>
<td>0.30</td>
<td>0.29</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.50</td>
<td>0.72</td>
<td>0.32</td>
<td>0.22</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>183.97M</td>
<td>179.57M</td>
<td>171.70M</td>
<td>169.30M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>172.15M</td>
<td>188.66M</td>
<td>184.34M</td>
<td>175.07M</td>
</tr>
</tbody>
</table>

To track all earnings releases for DMC Glb <a href="https://www.benzinga.com/quote/BOOM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

DMC Glb: Q4 Earnings Insights

DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.33 by 21.21 percent. The company reported quarterly sales of $174.04 million which beat the analyst consensus estimate of $170.30 million by 2.19 percent. This is a 0.59 percent decrease over sales of $175.07 million the same period last year.

Earnings Beats

Earnings Misses

DMC Glb Q4 2023 Adj EPS $0.26 Misses $0.33 Estimate, Sales $174.04M Beat $170.30M Estimate

Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

DMC Global Announces Strategic Alternatives Process For DynaEnergetics And NobelClad Businesses

Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Bristol-Myers Squibb </h3>
<ul>
<li>The Trade: Bristol-Myers Squibb Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmy#NYSE">BMY</a>) CEO Christopher Boerner <a href="https://www.benzinga.com/quote/EYPT/analyst-ratings"> acquired a total of 2,000 shares </a> an average price of $49.78. To acquire these shares, it cost around $99,560.</li>
<li>What&rsquo;s Happening: Bristol Myers Squibb released topline data from Phase 3 CheckMate -8HW trial of Opdivo (nivolumab) plus Yervoy (ipilimumab) compared to the investigator&rsquo;s choice of chemotherapy as a first-line treatment for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer.</li>
<li>What Bristol-Myers Squibb Does: Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders.</li>
</ul>
<h3>Matador Resources </h3>
<ul>
<li>The Trade: Matador Resources Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtdr#NYSE">MTDR</a>) Chairman and CEO Joseph WM Foran acquired a total of 2,000 shares at an average price of $54.30. To acquire these shares, it cost around $108,600.</li>
<li>What&rsquo;s Happening: On Oct. 24, Matador Resources posted upbeat quarterly results.</li>
<li>What Matador Resources Does: Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>First Busey </h3>
<ul>
<li>The Trade: First Busey Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/buse#NASDAQ">BUSE</a>) Director Stanley Bradshaw <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 4,200 shares </a> at an average price of $23.06. To acquire these shares, it cost around $96,852.</li>
<li>What&rsquo;s Happening: On Oct. 24, First Busey posted upbeat quarterly earnings.</li>
<li>What First Busey Does: First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana.</li>
</ul>
<h3>DMC Global </h3>
<ul>
<li>The Trade: DMC Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boom#NASDAQ">BOOM</a>) Director James Oleary <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 5,000 shares </a> at an average price of $16.39. The insider spent around $81,950 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 2, the company posted downbeat third-quarter results.</li>
<li>What DMC Global Does: DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36127763/i-like-it-very-much-jim-cramer-bullish-on-this-financial-stock-up-75-ytd"> &#39;I Like It Very Much&#39;: Jim Cramer Bullish On This Financial Stock Up 75% YTD </a>

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>Ranger Energy Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rngr#NYSE">RNGR</a>)</h3>
<ul>
<li>Ranger Energy Services reported worse-than-expected third-quarter revenue results and issued FY23 revenue guidance below estimates. Stuart Bodden, Ranger&rsquo;s Chief Executive Officer, commented, &quot;In the third quarter of 2023, Ranger continued to deliver strong financial performance despite lower U.S. onshore drilling and completions activity and sustained weakness in the natural gas basins.&quot; The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/RNGR">52-week low of $9.27 </a>.</li>
<li>RSI Value: 26.07</li>
<li>RNGR Price Action: Shares of Ranger Energy Services fell 0.6% to close at $9.92 on Tuesday.</li>
</ul>
<h3>DMC Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boom#NASDAQ">BOOM</a>)</h3>
<ul>
<li>DMC Global said its board of directors has elected James O&rsquo;Leary as an independent director. It <a href="https://www.benzinga.com/quote/BOOM"> has a 52-week low </a> of $14.82.</li>
<li>RSI Value: 28.21</li>
<li>BOOM Price Action: Shares of DMC Global fell 2.9% to close at $15.58 on Tuesday.</li>
</ul>
<h3>Kimbell Royalty Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/krp#NYSE">KRP</a>)</h3>
<ul>
<li>Kimbell Royalty Partners posted downbeat earnings for the third quarter. Robert Ravnaas, Chairman and Chief Executive Officer of Kimbell Royalty GP, LLC, Kimbell&#39;s general partner, commented, &quot;We are very pleased to announce another record quarter with new all-time highs set in production, rig count, DUCs and permits.&quot; The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/quote/KRP"> low of $13.85.</a></li>
<li>RSI Value: 28.24</li>
<li>KRP Price Action: Shares of Kimbell Royalty Partners fell 1.5% to close at $15.07 on Tuesday.</li>
</ul>
<h3>RPC, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/res#NYSE">RES</a>)</h3>
<ul>
<li>RPC posted weaker-than-expected results for the third quarter. &quot;RPC&#39;s third quarter 2023 operating results for the majority of our service lines were relatively stable sequentially except for the even weaker than expected decline in pressure pumping,&quot; stated Ben M. Palmer, RPC&#39;s President and Chief Executive Officer. The company&rsquo;s 52-week low is $6.54.</li>
<li>RSI Value: 29.33</li>
<li>RES Price Action: Shares of RPC fell 2.8% to close at $7.19 on Tuesday.</li>
</ul>
&nbsp;
W&amp;T Offshore, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wti#NYSE">WTI</a>)
W&amp;T Offshore posted downbeat earnings for the third quarter. Tracy W. Krohn, W&amp;T&rsquo;s Board Chair and Chief Executive Officer, commented, &ldquo;Our third quarter 2023 saw increased commodity pricing, strong production volumes, operational excellence and cost control which resulted in positive operational and financial results.&rdquo; The company <a href="https://www.benzinga.com/quote/WTI"> has a 52-week low </a> of $3.25.
RSI Value: 29.49
WTI Price Action: Shares of W&amp;T Offshore rose 0.3% to close at $3.31 on Tuesday.
Read More: <a href="https://www.benzinga.com/news/earnings/23/11/35994419/dollar-tree-salesforce-and-3-stocks-to-watch-heading-into-wednesday"> Dollar Tree, Salesforce And 3 Stocks To Watch Heading Into Wednesday </a>

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>)</h3>
<ul>
<li>The company reported a net loss of $85.2 million for third-quarter versus a year-ago net loss of $18.3 million. Thomas Meth, who continues as President, said, &quot;This was a disappointing quarter as our results came in meaningfully below our expectations due primarily to weakness in commercial activities.&quot; The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/EVA">52-week low of $0.6060 </a>.</li>
<li>RSI Value: 28.25</li>
<li>EVA Price Action: Shares of Enviva fell 5.1% to close at $1.31 on Tuesday.</li>
</ul>
<h3>Nine Energy Service, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nine#NYSE">NINE</a>)</h3>
<ul>
<li>Nine Energy Service reported third quarter revenues of $140.6 million. &quot;Third quarter revenue was in-line with expectations coming within our original guidance,&quot; said Ann Fox, President and Chief Executive Officer, Nine Energy Service. It <a href="https://www.benzinga.com/quote/NINE"> has a 52-week low </a> of $2.11.</li>
<li>RSI Value: 22.00</li>
<li>NINE Price Action: Shares of Nine Energy Service gained 0.5% to close at $2.14 on Tuesday.</li>
</ul>
<h3>MIND Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mind#NASDAQ">MIND</a>)</h3>
<ul>
<li>MIND Technology recently reported a reverse stock split. The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/quote/MIND"> low of $4.01.</a></li>
<li>RSI Value: 15.92</li>
<li>MIND Price Action: Shares of MIND Technology gained 0.9% to close at $4.8550 on Tuesday.</li>
</ul>
<h3>DMC Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boom#NASDAQ">BOOM</a>)</h3>
<ul>
<li>DMC Global said its board of directors has elected James O&rsquo;Leary as an independent director. The company&rsquo;s 52-week low is $14.82.</li>
<li>RSI Value: 27.37</li>
<li>BOOM Price Action: Shares of DMC Global gained 5.7% to close at $16.86 on Tuesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/23/11/35799463/varex-imaging-reports-weak-sales-joins-alcon-xpeng-and-other-big-stocks-moving-lower-in-wednesdays-p"> Varex Imaging Reports Weak Sales, Joins Alcon, XPeng And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session </a>

<h3>Gainers</h3>
<ul>
<li>Benson Hill, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhil#NYSE">BHIL</a>) shares jumped 48.1% to $0.3740.</li>
<li>Seres Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcrb#NASDAQ">MCRB</a>) climbed 45.9% to $1.20. Seres Therapeutics, on Thursday, posted a narrower-than-expected quarterly loss.</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrtea#NASDAQ">QRTEA</a>) surged 44% to $0.6181 following third-quarter results.</li>
<li>Cooper-Standard Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cps#NYSE">CPS</a>) shares climbed 41% to $17.94 following better-than-expected third-quarter results.</li>
<li>Tenon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnon#NASDAQ">TNON</a>) shares climbed 39.6% to $1.20 after the company announced it passed an FDA Level 2 Inspection.</li>
<li>Udemy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/udmy#NASDAQ">UDMY</a>) surged 38.1% to $12.46 following strong quarterly earnings.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) climbed 32.7% to $0.77.</li>
<li>Alpha Technology Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atgl#NASDAQ">ATGL</a>) gained 32.5% to $6.64. Alpha Technology Group recently announced the closing of its initial public offering of 1,750,000 ordinary shares at a public offering price of $4.00 per share.</li>
<li>Werewolf Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/howl#NASDAQ">HOWL</a>) rose 29.8% to $2.7888. Werewolf Therapeutics released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or metastatic solid tumors.</li>
<li>Enlivex Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enlv#NASDAQ">ENLV</a>) jumped 28.5% to $1.8250.</li>
<li>Syra Health Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syra#NASDAQ">SYRA</a>) gained 27.8% to $1.5981.</li>
<li>Dermata Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drma#NASDAQ">DRMA</a>) rose 26% to $0.76.</li>
<li>Redfin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) climbed 25.2% to $6.35 following third-quarter results.</li>
<li>Phoenix Motor Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pev#NASDAQ">PEV</a>) gained 25% to $0.93.</li>
<li>DarioHealth Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drio#NASDAQ">DRIO</a>) gained 24.7% to $1.2601.</li>
<li>CVRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvrx#NASDAQ">CVRX</a>) climbed 24.7% to $16.99. CVRx said Centers for Medicare and Medicaid Services has reassigned the Barostim implant procedure for procedures performed in the outpatient setting as part of the 2024 Medicare Hospital Outpatient Prospective Payment System final rule.</li>
<li>Net Lease Office Properties (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nlop#NYSE">NLOP</a>) gained 24% to $12.98.</li>
<li>Proto Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/prlb#NYSE">PRLB</a>) climbed 23.1% to $29.93. Proto Labs reported third-quarter FY2 revenue growth of 7.4% year-over-year to $130.71 million, beating the consensus of $122.77 million.</li>
<li>Definitive Healthcare Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dh#NASDAQ">DH</a>) gained 23.1% to $7.47 following upbeat quarterly results.</li>
<li>Editas Medicine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edit#NASDAQ">EDIT</a>) rose 23% to $8.65 following upbeat results.</li>
<li>Owens &amp; Minor, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/omi#NYSE">OMI</a>) jumped 23% to $19.09 following strong results.</li>
<li>Oatly Group AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otly#NASDAQ">OTLY</a>) rose 21.1% to $0.6399.</li>
<li>FIGS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/figs#NASDAQ">FIGS</a>) gained 21.1% to $6.80 after the company reported better-than-expected third-quarter sales results.</li>
<li>Integral Ad Science Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ias#NASDAQ">IAS</a>) jumped 19.6% to $14.19 following third-quarter results.</li>
<li>DermTech Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dmtk#NASDAQ">DMTK</a>) rose 19% to $1.6650 after the company reported better-than-expected third-quarter financial results.</li>
<li>Allogene Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allo#NASDAQ">ALLO</a>) gained 18.8% to $3.53 following third-quarter results.</li>
<li>Trupanion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trup#NASDAQ">TRUP</a>) climbed 18.8% to $27.19 after the company reported better-than-expected third-quarter financial results.</li>
<li>Knowles Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kn#NYSE">KN</a>) gained 18.8% to $16.06 following upbeat earnings.</li>
<li>The E.W. Scripps Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssp#NASDAQ">SSP</a>) jumped 18.5% to $7.23 following strong results.</li>
<li>Funko, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fnko#NASDAQ">FNKO</a>) climbed 18.5% to $8.90 after reporting upbeat results.</li>
<li>Hippo Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hipo#NYSE">HIPO</a>) shares rose 18.4% to $9.52 after the company reported better-than-expected third-quarter financial results.</li>
<li>Novo Integrated Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvos#NASDAQ">NVOS</a>) shares climbed 18% to $0.3051 after gaining more than 10% on Thursday.</li>
<li>DigitalOcean Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/docn#NASDAQ">DOCN</a>) rose 17.3% to $24.91 after the company reported better-than-expected third-quarter financial results and issued FY23 guidance.</li>
<li>Eiger BioPharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eigr#NASDAQ">EIGR</a>) shares gained 17% to $0.3533 after gaining more than 7% on Thursday.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) gained 16.8% to $6.11.</li>
<li>Lilium N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lilm#NASDAQ">LILM</a>) climbed 16.8% to $0.8517.</li>
<li>Gartner, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/it#NYSE">IT</a>) surged 15.5% to $ 389.51 after the company reported better-than-expected third-quarter financial results and raised FY23 guidance.</li>
<li>Expedia Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/expe#NASDAQ">EXPE</a>) gained 15.5% to $109.60 after the company reported better-than-expected third-quarter financial results, announced a $5 billion share repurchase authorization and reiterated full year guidance.</li>
<li>AMC Networks Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amcx#NASDAQ">AMCX</a>) climbed 14.8% to $15.14 following upbeat earnings.</li>
<li>Magna International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mga#NYSE">MGA</a>) rose 14.3% to $56.04 after the company reported better-than-expected third-quarter financial results.</li>
<li>Mercer International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/merc#NASDAQ">MERC</a>) jumped 13.9% to $9.41 following upbeat results.</li>
<li>Block, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sq#NYSE">SQ</a>) shares gained 13.5% to $49.92 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance.</li>
<li>American Axle &amp; Manufacturing Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axl#NYSE">AXL</a>) rose 13.4% to $7.38 following strong sales.</li>
<li>Altamira Therapeutics Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyto#NASDAQ">CYTO</a>) shares gained 9.9% to $0.1797 after gaining 5% on Thursday.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inseego Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/insg#NASDAQ">INSG</a>) shares fell 35% to $0.3370 after the company reported worse-than-expected third-quarter financial results.</li>
<li>Fox Factory Holding Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/foxf#NASDAQ">FOXF</a>) shares fell 34.4% to $54.54 after the company reported downbeat third-quarter results and issued weak fourth-quarter forecast.</li>
<li>enGene Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) dropped 32% to $12.91.</li>
<li>BILL Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bill#NYSE">BILL</a>) fell 28.4% to $64.07 after the company reported first-quarter results and lowered its FY24 revenue outlook.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) declined 25% to $0.7089 after the company announced the exercise of warrants and the issuance of new warrants in a private placement for $1.9 million in gross proceeds priced at-the-market.</li>
<li>agilon health, inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agl#NYSE">AGL</a>) fell 20.2% to $13.47 after the company reported third-quarter financial results.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) declined 19.2% to $2.8675.</li>
<li>Puyi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/puyi#NASDAQ">PUYI</a>) declined 18% to $5.00.</li>
<li>Fortinet Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftnt#NASDAQ">FTNT</a>) shares fell 16.8% to $47.92 after the company reported mixed third-quarter financial results and issued FY23 revenue guidance below estimates.</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) declined 16% to $0.11.</li>
<li>Ubiquiti Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ui#NYSE">UI</a>) fell 14.5% to $106.46 following quarterly results.</li>
<li>MBIA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mbi#NYSE">MBI</a>) declined 14.1% to $6.22 following third-quarter earnings.</li>
<li>Paylocity Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcty#NASDAQ">PCTY</a>) fell 13.4% to $148.79 following quarterly earnings.</li>
<li>AvidXchange Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avdx#NASDAQ">AVDX</a>) declined 12.6% to $7.64.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) fell 12.5% to $2.9650 following weak results.</li>
<li>VS Media Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vsme#NASDAQ">VSME</a>) shares fell 10.5% to $1.09 after gaining 41% on Thursday.</li>
<li>DMC Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boom#NASDAQ">BOOM</a>) fell 9.4% to $17.20 following weak results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/11/35587971/top-4-financial-stocks-that-may-collapse-this-quarter"> Top 4 Financial Stocks That May Collapse This Quarter</a>

Intraday Update

Movers

ALLO

AMCX

ATGL

AVDX

BHIL

BILL

BSFC

CVRX

CYTO

DMTK

DOCN

DRIO

DRMA

EDIT

EIGR

ENGN

ENLV

EXPE

FIGS

FNKO

FOXF

FTNT

HIPO

HOWL

INSG

LILM

MCRB

MERC

NEXI

NLOP

NVOS

OTLY

PBLA

PCTY

PRLB

PUYI

QRTEA

RDFN

RXRX

SYRA

TNON

TRUP

UDMY

VIVK

VSME

Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session

DMC Global Sees Q4 2023 Revenue $170M-$180M Vs $177.3M Est.

DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.54 by 7.41 percent. This is a 42.86 percent increase over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of $172.15 million which missed the analyst consensus estimate of $183.97 million by 6.43 percent. This is a 1.33 percent decrease over sales of $174.47 million the same period last year.

DMC Glb Q3 Adj EPS $0.50 Misses $0.54 Estimate, Sales $172.15M Miss $183.97M Estimate

U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Monday. Here are some big stocks recording gains in today&rsquo;s session.
<ul>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) shares surged 30% to $1.43 after the company announced a registered direct offering at $2 per share plus warrants.</li>
<li>United States Steel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) shares gained 26.1% to $28.66. United States Steel late Sunday rejected a buyout offer from rival steel manufacturer Cleveland-Cliffs Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clf#NYSE">CLF</a>) but welcomed the latter to participate in a formal review process.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) gained 19% to $2.3100.</li>
<li>Consolidated Water Co. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cwco#NASDAQ">CWCO</a>) jumped 13.3% to $25.64. Janney Montgomery Scott upgraded Consolidated Water from Neutral to Buy.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) surged 13.1% to $1.9450.</li>
<li>monday.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mndy#NASDAQ">MNDY</a>) jumped 12% to $174.51. Monday.com reported second-quarter revenue growth of 42% Y/Y to $175.7 million, beating the consensus of $169.2 million.</li>
<li>AMC Entertainment Hldg Pref Equity Units (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ape#NYSE">APE</a>) climbed 11.7% to $1.9883 after AMC gained court approval for its revised stock conversion plan.</li>
<li>Karat Packaging Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krt#NASDAQ">KRT</a>) gained 11.2% to $25.85.</li>
<li>Archer Aviation Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/achr#NYSE">ACHR</a>) surged 10.6% to $6.39. Archer closing oversubscribed PIPE as a part of $215 million investment round led by Stellantis.</li>
<li>FiscalNote Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/note#NYSE">NOTE</a>) jumped 10% to $2.7850.</li>
<li>DMC Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boom#NASDAQ">BOOM</a>) rose 8.4% to $23.39. Stifel maintained DMC Global with a Buy and raised the price target from $33 to $35.</li>
<li>Algoma Steel Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/astl#NASDAQ">ASTL</a>) gained 7.9% to $7.50.</li>
<li>2U, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/twou#NASDAQ">TWOU</a>) rose 7.7% to $4.19.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) jumped 7.6% to $13.34.</li>
<li>Karat Packaging Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krt#NASDAQ">KRT</a>) gained 7.5% to $24.99.</li>
<li>Cleveland-Cliffs Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clf#NYSE">CLF</a>) rose 5.5% to $15.49. Cleveland-Cliffs publicly announced that on July 28 it presented an offer to U.S. Steel&#39;s board to acquire 100% of the company for $17.50 per share in cash and 1.023 shares of Cleveland-Cliffs stock, representing a total consideration value of $35 per share.</li>
<li>Micron Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mu#NASDAQ">MU</a>) gained 5.1% to $67.68.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/08/33830946/quince-therapeutics-and-2-other-stocks-under-3-insiders-are-buying"> Quince Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying </a>

AAOI

ACHR

ASTL

CWCO

MNDY

NOTE

SMMT

SOUN

TWOU

Cleveland-Cliffs, United States Steel, monday.com And Other Big Stocks Moving Higher On Monday

Stifel analyst Stephen Gengaro maintains DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) with a Buy and raises the price target from $33 to $35.

Stifel Maintains Buy on DMC Glb, Raises Price Target to $35

<h3>Gainers</h3>
<ul>
<li>Tango Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tngx#NASDAQ">TNGX</a>) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.</li>
<li>Decibel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbtx#NASDAQ">DBTX</a>) gained 76% to $4.9150 after Regeneron announced it will acquire the company.</li>
<li>Benitec Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bntc#NASDAQ">BNTC</a>) jumped 75.8% to $3.3937. Benitec Biopharma reported pricing of $30 million underwritten public offering.</li>
<li>Renovaro Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/renb#NASDAQ">RENB</a>) shares gained 68.2% to $1.43 after the company and AI-focused GEDi Cube announced a binding, exclusive letter of intent to merge.</li>
<li>T Stamp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idai#NASDAQ">IDAI</a>) climbed 48.8% to $2.3518.</li>
<li>EBET, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ebet#NASDAQ">EBET</a>) surged 40.5% to $0.0405 on abnormally-high volume. The stock was set to be suspended at the opening of business today unless the company requested an appeal of Nasdaq&#39;s Listing Qualifications Department&#39;s determination.</li>
<li>Millennium Group International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgih#NASDAQ">MGIH</a>) gained 40% to $2.7003 on strong volume.</li>
<li>Science 37 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snce#NASDAQ">SNCE</a>) jumped 39.3% to $0.3765 following better-than-expected quarterly results.</li>
<li>BioNexus Gene Lab Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bglc#NASDAQ">BGLC</a>) gained 36.5% to $1.5699.</li>
<li>Kubient, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kbnt#NASDAQ">KBNT</a>) rose 33.7% to $0.63.</li>
<li>Oportun Financial Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oprt#NASDAQ">OPRT</a>) gained 31.3% to $6.90 following strong quarterly results.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstx#NASDAQ">PSTX</a>) climbed 31.3% to $2.60 following quarterly results.</li>
<li>Mirati Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrtx#NASDAQ">MRTX</a>) surged 30.1% to $36.17 after the company reported second-quarter financial results. Also, B. Riley Securities upgraded the stock from Neutral to Buy and announced a $45 price target.</li>
<li>Allbirds, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bird#NASDAQ">BIRD</a>) gained 29% to $1.65 after the company reported better-than-expected second-quarter financial results.</li>
<li>Array Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arry#NASDAQ">ARRY</a>) climbed 27.8% to $22.85 following a second-quarter earnings beat.</li>
<li>Computer Task Group, Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctg#NASDAQ">CTG</a>) gained 27.8% to $10.23 after the company announced it will be acquired by Cegeka for $10.50 per share.</li>
<li>LivePerson, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpsn#NASDAQ">LPSN</a>) rose 27.5% to $5.09 r after the company announced a second-quarter earnings beat. The company named John Collins as the Interim CEO.</li>
<li>PMV Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmvp#NASDAQ">PMVP</a>) gained 22.3% to $8.31 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Celsius Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celh#NASDAQ">CELH</a>) jumped 21.8% to $174.73 after the company reported better-than-expected second-quarter financial results.</li>
<li>United Insurance Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uihc#NASDAQ">UIHC</a>) gained 21.3% to $6.83.</li>
<li>DMC Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boom#NASDAQ">BOOM</a>) climbed 19.8% to $21.03 following quarterly results.</li>
<li>Dutch Bros Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bros#NYSE">BROS</a>) surged 19.8% to $33.55 after the company reported better-than-expected quarterly EPS results and issued FY23 guidance.</li>
<li>Azenta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azta#NASDAQ">AZTA</a>) gained 19.6% to $57.45 fter the company reported better-than-expected third-quarter financial results and issued fourth-quarter EPS guidance above estimates. Additionally, Needham raised its price target from $55 to $65 on the stock.</li>
<li>ThredUp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tdup#NASDAQ">TDUP</a>) climbed 19.5% to $3.85 after the company reported better-than-expected second-quarter financial results and issued revenue guidance. Also, Goldman Sachs raised its price target from $3 to $4 on the stock.</li>
<li>Planet Green Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plag#NASDAQ">PLAG</a>) rose 17.5% to $0.5670.</li>
<li>Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) climbed 16.2% to $ 9.33.</li>
<li>Rapid7, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rpd#NASDAQ">RPD</a>) gained 16% to $46.15 after the company reported better-than-expected second-quarter financial results and issued FY23 EPS guidance above estimates. Additionally, Morgan Stanley raised its price target from $48 to $52 on the stock.</li>
<li>Taboola.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbla#NASDAQ">TBLA</a>) jumped 15.7% to $3.8993 after the company reported better-than-expected second-quarter financial results and raised its FY23 revenue guidance.</li>
<li>Toast, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tost#NASDAQ">TOST</a>) rose 15.7% to $23.39 after the company reported mixed quarterly financial results and issued FY23 revenue guidance above estimates.</li>
<li>Marqeta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mq#NASDAQ">MQ</a>) gained 15.5% to $5.73 following strong quarterly sales.</li>
<li>SciPlay Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scpl#NASDAQ">SCPL</a>) rose 15.4% to $22.67 after the company reported better-than-expected second-quarter financial results.</li>
<li>Orthofix Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ofix#NASDAQ">OFIX</a>) gained 15.3% to $20.72 after the company reported better-than-expected second-quarter financial results and raised FY23 net sales guidance above estimates.</li>
<li>Axon Enterprise, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axon#NASDAQ">AXON</a>) climbed 14.5% to $201.29 after the company reported better-than-expected second-quarter financial results and raised its FY23 revenue guidance above estimates.</li>
<li>EMCORE Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/emkr#NASDAQ">EMKR</a>) shares rose 13.5% to $0.7653 after the company posted better-than-expected quarterly sales.</li>
<li>HNI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hni#NYSE">HNI</a>) rose 10.8% to $32.24 following strong quarterly earnings.</li>
<li>Akanda Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akan#NASDAQ">AKAN</a>) shares gained 10.1% to $0.6548.</li>
<li>Loop Media, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lptv#NYSE">LPTV</a>) shares climbed 8.3% to $ 5.73 after the company posted upbeat quarterly sales and announced strategic alignment with Microsoft Advertising.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) shares gained 6.1% to $2.1121 after reporting better-than-expected quarterly results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Palisade Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pali#NASDAQ">PALI</a>) shares dipped 64.3% to $0.69 after the company announced its U.S. Phase 2 PROFILE study evaluating LB1148 for post-surgical abdominal adhesions did not achieve the primary efficacy endpoint.</li>
<li>Tigo Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tygo#NASDAQ">TYGO</a>) fell 43.3% to $12.05 after the company reported worse-than-expected second-quarter sales results and issued third-quarter revenue guidance below estimates.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) fell 38% to $0.2099 after the company announced a $5 million public offering.</li>
<li>Nuvei Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvei#NASDAQ">NVEI</a>) fell 36.8% to $18.92 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) declined 41.3% to $4.52 after jumping 139% on Tuesday.</li>
<li>WeWork Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/we#NYSE">WE</a>) shares fell 37.6% to $0.1306 following second-quarter results.</li>
<li>Mallinckrodt plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mnk#NYSE">MNK</a>) fell 36.1% to $0.9260 following second-quarter results.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) dipped 36% to $1.52. Wheels Up is pursuing strategic options.</li>
<li>Upstart Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) fell 33.9% to $34.23. Upstart reported better-than-expected results for its second quarter, but issued weak revenue forecast for the third quarter.</li>
<li>Angi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angi#NASDAQ">ANGI</a>) dipped 32.4% to $2.6150 after the company reported worse-than-expected second-quarter financial results.</li>
<li>PubMatic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pubm#NASDAQ">PUBM</a>) fell 31.3% to $12.76 after the company issued weak third-quarter revenue guidance.</li>
<li>Veritone, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veri#NASDAQ">VERI</a>) fell 31.1% to $2.7550 after the company posted second-quarter results.</li>
<li>Missfresh Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mf#NASDAQ">MF</a>) declined 31.1% to $1.46.</li>
<li>KVH Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kvhi#NASDAQ">KVHI</a>) fell 31% to $6.01 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Expensify, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exfy#NASDAQ">EXFY</a>) shares declined 30.4% to $4.12 after the company reported downbeat results for its second quarter.</li>
<li>Vroom, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrm#NASDAQ">VRM</a>) fell 30% to $1.38 after the company reported worse-than-expected second-quarter sales results.</li>
<li>Seer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seer#NASDAQ">SEER</a>) fell 29.8% to $3.27 after the company reported worse-than-expected second-quarter revenue results.</li>
<li>BioLife Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blfs#NASDAQ">BLFS</a>) dropped 29.4% to $12.98 after the company reported worse-than-expected second-quarter financial results and issued FY23 revenue guidance below estimates.</li>
<li>Actelis Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asns#NASDAQ">ASNS</a>) declined 29.4% to $1.5463. The stock earlier spiked after the company received orders for its hybrid copper networking solutions to expedite IoT modernization of major highway and rail systems throughout Japan.</li>
<li>Agiliti, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agti#NYSE">AGTI</a>) fell 28% to $12.27 after the company reported mixed second-quarter financial results and issued FY23 adjusted EPS guidance below estimates.</li>
<li>Bright Minds Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drug#NASDAQ">DRUG</a>) fell 26.6% to $ 3.06.</li>
<li>2U, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/twou#NASDAQ">TWOU</a>) shares fell 26.4% to $3.15 following weaker-than-expected quarterly results.</li>
<li>Electra Battery Materials Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elbm#NASDAQ">ELBM</a>) tumbled 25.8% to $0.8463.</li>
<li>AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) fell 25.8% to $10.82 after the company reported downbeat second-quarter results and issued weak 2023 sales outlook.</li>
<li>FTC Solar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftci#NASDAQ">FTCI</a>) fell 25.5% to $2.5750 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Doximity, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/docs#NYSE">DOCS</a>) shares dropped 23.4% to $25.12 after the company issued weak sales forecast.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) shares fell 23.3% to $266.34. Super Micro Computer posted upbeat quarterly results, but issued weak sales outlook.</li>
<li>Open Lending Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpro#NASDAQ">LPRO</a>) fell 21.6% to $8.03 after the company reported second-quarter financial results.</li>
<li>Roblox Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rblx#NYSE">RBLX</a>) declined 21.7% to $29.52 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Cutera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cutr#NASDAQ">CUTR</a>) fell 21.6% to $13.53 after the company reported worse-than-expected second-quarter financial results.</li>
<li>FiscalNote Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/note#NYSE">NOTE</a>) declined 21.4% to $2.71 after the company reported worse-than-expected second-quarter financial results.</li>
<li>LegalZoom.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lz#NASDAQ">LZ</a>) fell 20.9% to $12.14 after the company reported second-quarter financial results and issued guidance for FY23.</li>
<li>Inspirato Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ispo#NASDAQ">ISPO</a>) shares fell 20.4% to $0.9543 after the company reported downbeat second-quarter results and issued weak sales outlook.</li>
<li>8x8, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eght#NASDAQ">EGHT</a>) fell 19.6% to $3.3850 after the company reported worse-than-expected second-quarter sales results and issued revenue guidance below estimates.</li>
<li>Infinity Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infi#NASDAQ">INFI</a>) declined 18.9% to $0.1062 after jumping over 45% on Tuesday.</li>
<li>Nerdy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrdy#NYSE">NRDY</a>) fell 16.7% to $ 4.2650 after the company reported second-quarter financial results.</li>
<li>DXP Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxpe#NASDAQ">DXPE</a>) declined 15.3% to $31.98 after the company reported worse-than-expected second-quarter financial results.</li>
<li>IAC Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iac#NASDAQ">IAC</a>) fell 15% to $57.03 after the company reported worse-than-expected second-quarter financial results.</li>
<li>CPI Card Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmts#NASDAQ">PMTS</a>) declined 13.7% to $24.33.</li>
<li>ZipRecruiter, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zip#NYSE">ZIP</a>) tumbled 10.4% to $15.59 following quarterly results. Evercore ISI Group downgraded ZipRecruiter from Outperform to Neutral and lowered the price target from $20 to $18.</li>
<li>DraftKings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dkng#NASDAQ">DKNG</a>) shares fell 9.2% to $28.81 after Penn Entertainment entered into an exclusive agreement with ESPN, which gives Penn exclusive rights to the ESPN Bet trademark for online sports betting in the U.S. for an initial 10-year term.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) shares declined 8.8% to $10.55. Lyft reported better-than-expected sales for its second quarter and issued strong forecast for the third quarter.</li>
<li>MicroVision, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvis#NASDAQ">MVIS</a>) declined 8.1% to $3.0225 following weak quarterly results.</li>
<li>Sony Group Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sony#NYSE">SONY</a>) fell 7.3% to $83.29 after the company reportedly said a smartphone market recovery was not expected until 2024.</li>
<li>Tilray Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) fell 5.3% to $2.8601. Tilray Brands shares jumped 36% on Tuesday after the company announced an agreement to acquire eight beer and beverage brands from Anheuser-Busch.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/08/33668446/bitcoin-soars-past-30-000-aptos-emerges-as-top-gainer"> Bitcoin Soars Past $30,000; Aptos Emerges As Top Gainer </a>

AGTI

AKAN

ANGI

ARRY

ASLE

ASNS

AVXL

AXON

AZTA

BGLC

BIRD

BLFS

BNTC

BROS

BRSH

CELH

CUTR

DBTX

DKNG

DOCS

DRUG

DXPE

EBET

EGHT

ELBM

EMKR

EXFY

FTCI

IDAI

INFI

ISPO

KBNT

KVHI

LPRO

LPSN

LPTV

LYFT

MGIH

MRTX

MVIS

NRDY

NVEI

OFIX

OPRT

PALI

PLAG

PMTS

PMVP

PSTX

PUBM

RBLX

RENB

SCPL

SEER

SMCI

SNCE

Sony Group Corporation American Depositary Shares

SONY

TBLA

TDUP

TLRY

TNGX

TOST

TYGO

UIHC

UPST

VERI

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today&rsquo;s session.
<ul>
<li>Tango Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tngx#NASDAQ">TNGX</a>) gained 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.</li>
<li>Decibel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbtx#NASDAQ">DBTX</a>) rose 76% to $4.9150 after Regeneron announced it will acquire the company.</li>
<li>Mirati Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrtx#NASDAQ">MRTX</a>) climbed 30.1% to $36.17 after the company reported second-quarter financial results. Also, B. Riley Securities upgraded the stock from Neutral to Buy and announced a $45 price target.</li>
<li>Array Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arry#NASDAQ">ARRY</a>) gained 27.8% to $22.85 following a second-quarter earnings beat.</li>
<li>Computer Task Group, Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctg#NASDAQ">CTG</a>) rose 27.8% to $10.23 after the company announced it will be acquired by Cegeka for $10.50 per share.</li>
<li>LivePerson, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpsn#NASDAQ">LPSN</a>) gained 27.5% to $5.09 r after the company announced a second-quarter earnings beat. The company named John Collins as the Interim CEO.</li>
<li>PMV Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmvp#NASDAQ">PMVP</a>) climbed 22.3% to $8.31 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Celsius Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celh#NASDAQ">CELH</a>) rose 21.8% to $174.73 after the company reported better-than-expected second-quarter financial results.</li>
<li>DMC Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boom#NASDAQ">BOOM</a>) gained 19.8% to $21.03 following quarterly results.</li>
<li>Dutch Bros Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bros#NYSE">BROS</a>) climbed 19.8% to $33.55 after the company reported better-than-expected quarterly EPS results and issued FY23 guidance.</li>
<li>Azenta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azta#NASDAQ">AZTA</a>) rose 19.6% to $57.45 fter the company reported better-than-expected third-quarter financial results and issued fourth-quarter EPS guidance above estimates. Additionally, Needham raised its price target from $55 to $65 on the stock.</li>
<li>ThredUp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tdup#NASDAQ">TDUP</a>) gained 19.5% to $3.85 after the company reported better-than-expected second-quarter financial results and issued revenue guidance. Also, Goldman Sachs raised its price target from $3 to $4 on the stock.</li>
<li>Taboola.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbla#NASDAQ">TBLA</a>) gained 17% to $3.9450 after the company reported better-than-expected second-quarter financial results and raised its FY23 revenue guidance.</li>
<li>Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) jumped 16.2% to $ 9.33.</li>
<li>Rapid7, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rpd#NASDAQ">RPD</a>) rose 16% to $46.15 after the company reported better-than-expected second-quarter financial results and issued FY23 EPS guidance above estimates. Additionally, Morgan Stanley raised its price target from $48 to $52 on the stock.</li>
<li>Toast, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tost#NASDAQ">TOST</a>) jumped 15.7% to $23.39 after the company reported mixed quarterly financial results and issued FY23 revenue guidance above estimates.</li>
<li>Marqeta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mq#NASDAQ">MQ</a>) rose 15.5% to $5.73 following strong quarterly sales.</li>
<li>IDEAYA Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idya#NASDAQ">IDYA</a>) jumped 15.5% to $24.93 after SVB Leerink initiated coverage on the stock with an Outperform rating and announced a $33 price target.</li>
<li>SciPlay Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scpl#NASDAQ">SCPL</a>) gained 15.4% to $22.67 after the company reported better-than-expected second-quarter financial results.</li>
<li>Orthofix Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ofix#NASDAQ">OFIX</a>) jumped 15.3% to $20.72 after the company reported better-than-expected second-quarter financial results and raised FY23 net sales guidance above estimates.</li>
<li>Axon Enterprise, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axon#NASDAQ">AXON</a>) surged 14.5% to $201.29 after the company reported better-than-expected second-quarter financial results and raised its FY23 revenue guidance above estimates.</li>
<li>Arcturus Therapeutics Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arct#NASDAQ">ARCT</a>) rose 13.3% to $29.15.</li>
<li>Liberty Latin America Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lila#NASDAQ">LILA</a>) gained 13% to $9.49 after the company reported second-quarter revenue results..</li>
<li>Blink Charging Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blnk#NASDAQ">BLNK</a>) jumped 12.9% to $6.98 after the company reported better-than-expected second-quarter financial results.</li>
<li>Oscar Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oscr#NYSE">OSCR</a>) rose 12.7% to $8.04 following quarterly results.</li>
<li>HNI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hni#NYSE">HNI</a>) gained 10.8% to $32.24 following strong quarterly earnings.</li>
<li>Vertex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verx#NASDAQ">VERX</a>) rose 9.9% to $19.53 after the company reported better-than-expected second-quarter revenue results and issued third-quarter revenue guidance above estimates.</li>
<li>PENN Entertainment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/penn#NASDAQ">PENN</a>) rose 9.8% to $27.27 after the company reported better-than-expected second-quarter financial results and announced an exclusive U.S. online sports betting agreement with ESPN.</li>
<li>Zai Lab Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zlab#NASDAQ">ZLAB</a>) gained 9.7% to $26.52.</li>
<li>Duolingo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duol#NASDAQ">DUOL</a>) gained 9.3% to $148.66 after the company reported better-than-expected second-quarter financial results.</li>
<li>Coupang, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cpng#NYSE">CPNG</a>) rose 8.5% to $19.44 after the company reported better-than-expected second-quarter financial results.</li>
<li>Akamai Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akam#NASDAQ">AKAM</a>) gained 8.4% to $102.91 after the company reported better-than-expected second-quarter financial results and issued FY23 adjusted EPS and revenue guidance above estimates.</li>
<li>The Goodyear Tire &amp; Rubber Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gt#NASDAQ">GT</a>) rose 5% to $13.49.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/23/08/33667558/genpact-gears-up-for-q2-print-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call"> Genpact Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call </a>

AKAM

ARCT

BLNK

CPNG

DUOL

IDYA

LILA

OSCR

PENN

VERX

ZLAB

Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday

WIIM

DMC Global shares are trading higher after the company reported better-than-expected Q2 financial results.

DMC Global Sees Q3 Revenue $178M-$188M Vs $179.4M Est; Capital Expenditures $5M-$7M

DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.41 by 75.61 percent. This is a 148.28 percent increase over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $188.66 million which beat the analyst consensus estimate of $179.57 million by 5.06 percent. This is a 13.77 percent increase over sales of $165.83 million the same period last year.

DMC Glb Q2 Adj $0.72 Beats $0.41 Estimate, Sales $188.66M Beat $179.57M Estimate

DMC Global Inc (BOOM) has released an update to notify the public and investors about a regulation fd disclosure. Discover the latest update from t...

DMC Global Unveils Key Insights in Non-Filed Disclosure

DMC Global Inc (BOOM) has released an update to notify the public and investors about its financial commitment initiation. The summary highlights k...

DMC Global Inc Announces New Financial Obligation Creation